Prophylactic infusion of multi-virus specific T cells for management of viral reactivation and infection in patients post allogeneic hematopoietic stem cell transplantation (HSCT)

      We present the preliminary data on a phase I/II clinical trial administering multi-virus specific T cells prophylactically to patients who have undergone HSCT.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Cytotherapy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect